Tuberculosis (TB) control in the African Region has evolved since the disease was declared a global emergency by the World Health Organization (WHO) in 1993. Member States have adopted and implemented successive global and regional strategies and resolutions, with demonstrable positive impacts on in...cidence, prevalence and mortality, albeit with variations across countries. By the end of 2015, the Region as a whole met the key Millennium Development Goal (MDG) target of halting and beginning to reverse TB incidence. However only 35 of the 47 Member States met the MDG target.
more
In low- and middle-income middle-income countries, reliable and disaggregated disability data on prevalence, participation and barriers are often unavailable. This study aimed to estimate disability prevalence, determine associated socio-demographic factors and compare access in the community betwee...n people with and without disability in Dehradun district of Uttarakhand, India, using the Rapid Assessment of Disability survey.
more
The effect of music intervention on mild and moderate Intellectually
disabled children was studied in non-randomized pre-test post-test control
group design at an Indian state (Jammu) J&K
Recommendations, resources and references
A publication of the Southern African HIV Clinicians Society
Rapport de Suivi de la Déclaration de Politique du Bénin
À l’instar des autres pays de la sous-région, le Bénin est un pays à épidémie mixte. Depuis 2006, la prévalence du VIH s’est stabilisée à 1,2% dans la population générale. Malgré cette tendance à la stabilisation, il exi...ste des poches de concentration de fortes prévalences au sein de certaines populations clés plus exposées aux risques d’infection, notamment les professionnelles de sexe (PS), les détenus, les HSH et les CDI.
more
Key populations brief
Accessed November 2017
Lessons from the STEP-TB Project.
Accessed November 2017.
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Doc. No.: INS/GDL/001-(Annexes)
HIV drug resistance , Users Manual
December 2017
Guidelines
June 2017
HIV strategic information for impact
The International Journal of Tuberculosis and Lung Disease 21(5) DOI: 10.5588/ijtld.16.0518